Ministry Issues Warning Against 'Very High' UV Index In Canary Island, Know Why It Matters

Updated Feb 25, 2025 | 10:41 AM IST

Summary The Ministry of Health for this holiday destination has urged both, residents and visitors to take extra precautions and preventative measures to limit the impact of sun exposure over their body and skin.
High UV Index in Carnay Islands

Credits: Canva

When the sun is out after a long winter, every one loves it. But not the people of Canary Islands. Tourists there are being warned about the "unusually high risk" of UV rays this week. The Ministry of Health for this holiday destination has urged both, residents and visitors to take extra precautions and preventative measures to limit the impact of sun exposure over their body and skin.

The Ministry observed Aemet, Spain's national weather agency for the forecast which showed higher than normal UV or ultraviolet radiation levels in the region. It is in this backdrop that everyone in the region are requested to be extra careful when they are out in the sun. UV levels are set to reach 7, which is a 'high risk' in La Palma, El Hierro, La Gomera and Gran Canaria. Other regions like Tenerife, Fuerteventura and Lanzarote are expected to reach a level 6, which is also classed as 'high risk'.

UV Index Explained

As per the World Health Organization (WHO), a UV index is a measure of the level of UV radiation, which ranges from zero upward. The higher the UVI, the greater potential for damage to skin and eye and the less time it takes for harm to occur, notes WHO.

The range 1 to 2 represents a low risk, 2 to 5 is moderate, 6 to 7 is at high risk, 8 to 10 is at very high and anything over 11 is extremely risky for anyone to stay out.

UV radiation levels fluctuate throughout the day, with the highest values occurring during the four-hour period around solar noon. The reported UV Index (UVI) typically reflects this daily peak. Depending on geographic location and the use of daylight saving time, solar noon falls between 12 p.m. and 2 p.m. In some countries, sun protection advisories are issued when UV levels are expected to reach 3 or higher, as exposure at these levels increases the risk of skin damage, making protective measures essential.

What happens to you when you are out in sun for too long?

While sun bathing is good, being out in the sun when the UVI indicates a high or very high risk, may cause you health concerns. It can lead to sunburn, premature skin aging, incresed risk of skin cancer, eye damage and in severe cases, heat related disease.

Sunburn

It is one of the most common skin injury which happens when there is excess exposure to UV radiation from the sun. This happens when the UV radiation directly damages the DNA skin cells. These damaged cells die and shed, this is why people experience peeling after getting a sunburn.

Dehydration

This is also a common occurrence when your body loses too many fluids or electrolytes. It can also interfere with your normal body functions. You may feel dehydrated, especially when you are out in the sun, but not well hydrated. The most common symptoms are dizziness, fatigue and headache on hot days.

Hyponatremia

This is an electrolyte disorder in which your body experiences low sodium in blood. The symptoms could lead to nausea, confusion and even weakness. There are extreme cases when one may have seizures, slip into coma or die.

Heat Exhaustion

This is one of the most common consequence of being out under the hot sun. Dehydration with prolonged heat exposure can lead to heat exhaustion.

Heatstroke

When you are out under the sun and your body's core temperature cross 104°, heatstroke may occur. This is also known as sunstroke. As per the Centers for Disease Control and Prevention (CDC), it causes more than 600 deaths each year in the United States.

End of Article

Christina Applegate Reveals Multiple Sclerosis Misdiagnosis: Why The Disease Is Hard To Diagnose

Updated Oct 20, 2026 | 10:00 PM IST

SummaryDespite being told she did not have MS, Christina Applegate said her debilitating symptoms persist. She still relies on a wheelchair to visit her doctor and struggles to walk even short distances. She also expressed confusion and distress over not knowing what is causing her ongoing symptoms.
Christina Applegate Reveals Multiple Sclerosis Misdiagnosis: Why The Disease Is Hard To Diagnose commons.wikimedia

Credit: Wikimedia Commons

Emmy-winning American actor Christina Applegate has in a shocking news revealed that she does not have multiple sclerosis (MS), despite continuing to experience debilitating symptoms since her 2021 diagnosis.

Applegate, 54, shared the news in an episode of her podcast MeSsy, co-hosted with fellow actor Jamie-Lynn Sigler and posted to YouTube on Tuesday.

“I’m back at square one – that I don’t know what’s going on with me,” she said through tears.

Applegate had gradually withdrawn from public life after her MS diagnosis in 2021, as she navigated the physical and emotional toll of the condition.

She has also become an advocate for MS awareness and chronicled her struggles in an emotional memoir published in March.

Christina Applegate Recalls Learning About Her Misdiagnosis

Also read: Why Multiple Sclerosis Increases Emotional Burden Among Women

Applegate recalled a visit to her doctor when she was told she did not have MS.

“She came into my room and said, ‘Congratulations, you don’t have MS,’” Applegate recalled through tears. “I was, like, not happy at all. Everybody else was so happy.”

Despite the news, Applegate said her symptoms have not improved.

“I haven’t gotten better. I still have to use wheelchairs when I go to the doctor’s office. I can’t walk from the car to the room. I’m still in this. Nothing magical happened when she said, ‘You don’t have MS.’ Nothing magical happened.”

Applegate also described feeling confused about her condition and the uncertainty surrounding her symptoms.

“It’s weird because I feel like I let everybody down. It’s this weird feeling of like I became this, you and I, the poster children for MS. Everything that I was doing, I had a fucking reason as to why my day sucked every day.

“And now I don’t have a reason. It’s very unnerving and it’s really confusing for me.”

What Is Multiple Sclerosis?

Read More: Selena Gomez Says Vaping Changed Her Voice: How E-Cigarettes Affect Vocal Cords

According to the National Institute of Neurological Disorders and Stroke, multiple sclerosis is a chronic neurological condition that affects the central nervous system, including the brain, spinal cord and optic nerves.

MS is also an immune-mediated disease in which the immune system attacks myelin, the protective sheath surrounding nerve fibers. Damage to myelin can disrupt nerve signals, causing symptoms that vary from person to person.

These may include muscle weakness, fatigue, numbness, coordination problems, vision changes and memory difficulties.

MS is commonly diagnosed between the ages of 20 and 40, although it can develop earlier or later. There is no cure, but treatments can help manage symptoms and slow disease progression. Some people experience relapses with periods of improvement, while others develop progressively worsening disability.

Why Is Multiple Sclerosis Hard To Diagnose?

Dr. Marwa Kaisey, an associate professor in the Department of Neurology at Cedars-Sinai Medical Center, joined Applegate and Sigler on the podcast to discuss MS misdiagnosis.

Kaisey said misdiagnoses are “fairly common” because there is no single test that can definitively confirm or rule out MS.

“We don’t have one single test for MS. It’s not like we have something like a pregnancy test that says, ‘Yes. You have it.’ ‘No. You don’t.’ It’s a list of criteria.”

Kaisey said nearly 20% of people diagnosed with MS may not actually have the disease, People.com reported.

“Almost one in five of these people who’d been told they had MS, some for decades, didn’t actually have it. And a majority of them were on medication to treat their MS,” she said.

MS diagnosis typically involves assessing symptoms, a neurological examination, magnetic resonance imaging (MRI) and, when appropriate, additional tests to rule out other conditions.

Because several disorders can cause similar symptoms, clinicians must evaluate the findings against established diagnostic criteria.

End of Article

American COVID Drives Cases And Deaths In UK: Unusual XFG Symptoms To Watch For

Updated Oct 20, 2026 | 09:16 PM IST

SummaryUK COVID-19 cases rose 13.5% in the week to October 7, with 3,942 cases recorded so far this month. Deaths increased 46.4%, from 28 to 41, in the week ending October 2, according to UK Health Security Agency data.
American COVID Drives Cases And Deaths Up In UK: Unusual XFG Symptoms To Watch For

Credit: iStock

The UK is seeing a rise in COVID-19 infections ahead of winter, with the XFG variant, also known as Stratus, among the circulating strains.

Cases, hospital admissions and deaths have increased, while flu and respiratory syncytial virus (RSV) are also concerns heading into the colder months.

COVID Cases And Deaths Rise In UK

Latest UK Health Security Agency (UKHSA) data show around 2.46 COVID-19 hospital admissions per 100,000 people each week.

The UK recorded 3,942 confirmed cases in October so far, compared with 4,589 in September and 1,374 in August.

People aged 85 and older remain the most vulnerable, with almost 27 hospital admissions per 100,000 people, more than 10 times the national average. Around 13.5% of this age group tested positive, compared with 8.8% across all age groups.

COVID-19 deaths rose 46.4%, from 28 to 41, in the week ending October 2. Cases increased 13.5% in the week to October 7, according to UKHSA data.

American COVID Drives Cases And Deaths Up In UK: Unusual XFG Symptoms To Watch For

Unusual COVID Symptoms: Red And Itchy Eyes

Also read: XFG Variant In Spain: COVID-19 Cases Rise Amid Respiratory Infection Surge

A persistent cough, fever and sore throat are familiar COVID-19 symptoms. However, eye irritation and conjunctivitis may also signal infection, pharmacist Noel Wicks told The Mirror.

“The COVID-19 virus can enter the body through our eyes where it may cause symptoms.”

Wicks said conjunctivitis, which causes red, irritated and sometimes sticky eyes, can occur even without other COVID-19 symptoms.

“Clinical studies have demonstrated that conjunctivitis (red eye) is present in people who test positive for coronavirus, with rates of conjunctivitis ranging from 2% to over 14%, even if people don’t have any other COVID symptoms. In fact, conjunctivitis can be the first and/or the only symptom of COVID,” he said.

Research involving 6,308 people found that approximately 11% of COVID-19 patients experienced eye symptoms. These included conjunctivitis, dryness, redness, watering and itching.

Signs Of COVID-Related Conjunctivitis

Read More: XFG COVID Variant: What India Should Watch As Cases Rise In UK And France

According to Wicks, symptoms may include:

  • Pink or red whites of the eyes
  • Sore or inflamed eyelids
  • Gritty, itchy eyes
  • White or yellow discharge

“These symptoms need to be tackled very quickly,” he said.

There is no established evidence that XFG causes eye symptoms more frequently than other COVID-19 variants. Allergies, bacterial infections and other viruses can also cause eye irritation, so these symptoms alone cannot confirm COVID-19.

How To Manage Eye Irritation

Wicks recommends gently cleaning the eyes, avoiding rubbing them and temporarily stopping contact lens use and eye makeup until symptoms improve.

“Make sure to keep your eyes clean by washing them gently with a clean flannel to remove any crusts. Don’t rub your eyes as this can transfer infection from your hands to your eyes. Remove contact lenses and don’t wear eye makeup until the infection is better,” he advised.

Persistent irritation warrants advice from a healthcare professional. Eye pain, sensitivity to light or changes in vision require urgent medical assessment.

What Is The COVID XFG Variant?

XFG, also known as Stratus, is a recombinant Omicron lineage formed when two Omicron sub-lineages combined. The World Health Organization classified it as a variant under monitoring in 2025 because of its growth advantage.

Although XFG carries mutations in its spike protein, studies suggest its ability to evade immunity differs only slightly from that of other JN.1 descendants.

There is no evidence that XFG causes more severe illness than other circulating Omicron variants. However, increased transmission can still raise hospital admissions by increasing the overall number of infections.

End of Article

Fatty Liver Disease: Scientists Identify 5 Subtypes With Different Health Risks

Updated Oct 20, 2026 | 05:00 PM IST

SummaryResearchers also identified associations between specific subtypes and conditions such as depression, sleep apnea and migraine. These links suggest that the biological processes underlying some forms of fatty liver disease may also be associated with health problems affecting other parts of the body.
Fatty Liver Disease: Scientists Identify 5 Subtypes With Different Health Risks

Credit: iStock

Fatty liver disease, which affects nearly 30% of adults worldwide, may comprise five biologically distinct subtypes, according to new research.

Researchers from the Mayo Clinic and Virginia Tech in the US found that each subtype may carry different risks of liver failure, cancer, heart disease and other serious complications.

The study, published in Nature Communications, suggests that metabolic dysfunction-associated steatotic liver disease (MASLD) can develop through different biological pathways. Some are closely linked to obesity and diabetes, while others appear to be driven by inherited genetic factors.

The findings suggest that genetic forms of the disease may progress to advanced liver damage even in people without typical metabolic risk factors.

Why Fatty Liver Disease Can Be Dangerous

Also read: NAFLD to MASLD: Experts Explain Why This Common Yet Dangerous Liver Condition Got Renamed

MASLD, previously known as nonalcoholic fatty liver disease, develops when excess fat accumulates in the liver. Many people experience no noticeable symptoms, allowing the condition to go undetected for years.

Although the disease does not always cause serious complications, it can progress to inflammation, scarring and permanent liver damage. In advanced cases, it may lead to cirrhosis, in which extensive scarring impairs liver function.

MASLD is a major contributor to cirrhosis, liver cancer and liver transplantation worldwide. Understanding why some patients develop severe complications while others do not is therefore an important research priority.

Genetic Analysis Reveals Five Distinct Subtypes

To investigate the differences, the researchers analyzed genetic sequencing results alongside detailed medical records from more than 4,600 patients with MASLD.

The data included liver enzyme measurements, body mass index, blood lipid levels and other indicators of metabolic health. The researchers also examined coexisting conditions, including diabetes, depression and sleep apnea.

Using computational models, they identified five groups of patients who shared distinct biological characteristics. The findings suggest that people with the same MASLD diagnosis may have different underlying disease processes and risks of complications.

“When clinical and genomic data are analyzed together at this scale, you begin to see patterns of disease progression that would otherwise remain hidden,” said Shulan Tian, Ph.D., co-senior author and a bioinformatician at Mayo Clinic. “Once you separate these subtypes, you can start to match treatments to the biology that's actually driving the disease.”

Links to Depression, Sleep Apnea and Migraines

Read More: Lancet Study Shows Metabolic Liver Disease To Rise Over 38% By 2050: What’s Behind The Surge

The findings also suggest that the differences between MASLD subtypes extend beyond the liver.

Researchers identified associations between specific subtypes and conditions such as depression, sleep apnea and migraine. These links suggest that the biological processes underlying some forms of fatty liver disease may also be associated with health problems affecting other parts of the body.

However, the findings do not establish that MASLD directly causes these conditions.

Could the Findings Improve Treatment?

Identifying distinct subtypes could eventually help doctors recognize high-risk patients earlier, improve screening and develop more personalized treatment strategies.

Eric Klee, a research and innovation leader at Mayo Clinic, said the approach could help researchers better understand disease progression and identify opportunities to intervene before severe damage occurs.

The team plans to evaluate the findings in larger and more diverse patient populations and investigate whether the subtypes respond differently to treatments, including GLP-1 receptor agonists.

If further studies validate the results, the research could help move MASLD care toward earlier intervention and treatments tailored to the biological processes driving each patient's disease.

End of Article